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Abstract
Neurotropic recombinant strain of Mouse Hepatitis Virus, RSA59, induces meningo-encephalitis, myelitis and demyelination
following intracranial inoculation. RSA59 induced neuropathology is partially caused by activation of CNS resident microglia,
as demonstrated by changes in cellular morphology and increased expression of a microglia/macrophage specific calcium
ion binding factor, Iba1. Affymetrix Microarray analysis for mRNA expression data reveals expression of inflammatory
mediators that are known to be released by activated microglia. Microglia-specific cell surface molecules, including CD11b,
CD74, CD52 and CD68, are significantly upregulated in contrast to CD4, CD8 and CD19. Protein analysis of spinal cord
extracts taken from mice 6 days post-inoculation, the time of peak inflammation, reveals robust expression of IFN-c, IL-12
and mKC. Data suggest that activated microglia and inflammatory mediators contribute to a local CNS microenvironment
that regulates viral replication and IFN-c production during the acute phase of infection, which in turn can cause
phagolysosome maturation and phagocytosis of the myelin sheath, leading to demyelination.
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Introduction
There is a fundamental distinction between acute and chronic
inflammation in various pathological studies. Acute inflammation
comprises the immediate and early response to an injurious agent
and is basically a defensive response that paves the way for repair
of the damaged site. The term ‘‘neuroinflammation’’ is appropri-
ate where limited neuronal insults trigger glial cell activation [1].
Neuroinflammation revolves around direct neuro-glial cell re-
sponses (host cell factors) which are induced by infection and
injury within the CNS. It also involves the mechanism by which
these responses ultimately contribute to neuropathology and
neurobiology of diseases.
Microglia are the resident macrophage-like population in the
central nervous system (CNS). Microglia remain quiescent in the
CNS, unable to perform effector and APC functions until
activated by injury or infection, and have been suggested to
represent the first line of defence for the CNS, which normally
lacks professional APCs until they are recruited to the CNS by
inflammatory stimuli. Previous studies demonstrated that microg-
lia can be persistently infected by neurotropic strains of Mouse
hepatitis virus (MHV) [2].
Neurotropic MHV infection in mice causes meningoencepha-
litis, myelitis, and demyelination associated with pronounced
activation of microglia. This is evident from characteristic changes
in microglial cellular morphology and presence of abundant
phagocytotic microglia in demyelinating plaques. MHV-induced
CNS injury during early stage of infection involves microglia
mediated neuroinflammation. But the mechanism by which these
inflammatory responses ultimately contribute to MHV-induced
demyelination and axonal loss is not clear. To understand
neuroinflammatory pathways, expression of host inflammatory
genes in MHV-infected mouse spinal cord is evaluated in
comparison to non-infected mouse spinal cord by high throughput
affymetrix microarray analysis. Brain and liver tissues from
infected mice were evaluated for routine histopathological
outcomes. Simultaneously, a high throughput Meso Scale
Discovery (MSD)) Multi-Array Assay system for Mouse cytokines
was performed to determine the predominant neuroinflammatory
pathways involved in microglia-mediated myelin destruction.
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Material and Methods
Ethics Statement
Use of animals and all experimental procedures were reviewed
and approved by the Institutional Animal Care and Use Committee
at the University of Pennsylvania, Philadelphia. Animal protocols
adhered to the guidelines of the United States National Institutes
of Health Office of Laboratory Animal Welfare Guide for the
Care and Use of Laboratory Animals, 8th Edition.
Virus
RSA59 is recombinant isogenic demyelinating (DM) strain of
MHV [3,4]. RSA59 is isogenic to parental MHV-A59 but the
spike gene is introduced by targeted RNA recombination. Spike
gene encodes an envelope glycoprotein that mediates many
biological properties of MHV including viral attachment to host
cells, as well as virus-cell and cell-cell fusion [5]. These
recombinant strains also express enhanced green fluorescence
protein (EGFP) [3]. Briefly, the pMH54 plasmid (obtained from
Paul S. Masters) comprises codon 28 of the hemagglutinin esterase
(HE) pseudogene through to the 39 end of the MHVA59 genome,
including a poly(A) tail, as described by [6], used as transcription
vector to generate RNA for targeted recombination as described
previously [7,8]. In order to replace gene 4 with the EGFP gene,
pMH54 was modified by the introduction of a SalI site 42
nucleotides downstream of the intergenic sequence for gene 4a
and a NotI site 102 bp upstream of the stop codon for gene 4b,
using the Quick Change site-directed mutagenesis kit (Stratagene,
La Jolla, CA). Targeted RNA recombination was carried out
between synthetic capped RNAs transcribed from pMH54EGFP,
using a T7 polymerase transcription kit (Ambion, Austin, TX) and
fMHV as a recipient virus. Recombinant viruses in which the
murine coronavirus spike gene has replaced the feline coronavirus
spike gene were selected by replication in murine 17 Cl-1 cells
[6,9]. Candidate recombinants were plaque purified two times,
and viral stocks were grown on 17Cl-1 cell for further
characterization. For each desired recombinant, at least two
viruses derived from independent recombination events were
characterized. The EGFP containing viruses with the A59 spike
were called RSA59 and used in this study.
Inoculation of mice
Four-week-old, MHV-free, C57BL/6 (B6) mice (Jackson
Laboratory) were inoculated intracranially with 50% LD50 dose
of RSA59 strain (20,000 PFU) as described previously [10]. Five
mice in each group were infected. Mice were monitored daily for
signs of disease. Mock-infected controls were inoculated similarly
but with an uninfected cell lysate at a comparable dilution. At day
6 post infection 3 mice were perfused with 40 ml of PBS 1x
(treated with DEPC) and whole spinal cord, half of the brain and a
piece of liver tissue were harvested for extraction of RNA and
stored in RNA later solution at 280uC until extraction. The
remaining liver and half brain were post fixed in 4% paraformal-
dehyde for parallel histopathological analysis. Two mice from each
group were sacrificed for routine histopathological tissue process-
ing. Two mice in control and three mice in the RSA59 infected
group were analyzed in the microarray experiment. However,
after the parallel histological analysis demonstrated that one of the
RSA59 infected mice did not exhibit signs of infection, suggesting
inoculation was unsuccessful, data from this mouse was removed
from subsequent analyses.
RNA extraction
RNA was extracted from 30 mg of brain, spinal cord and liver
tissues from mock infected mice and viral infected mice with
RNeasy mini kits (Qiagen, Chatsworth, CA) according to the
manufacturer’s instructions. The quantity of total RNA was
assessed using a NanoDrop ND-100 spectrophotometer. One mg
of total RNA was used to synthesize cDNA with high capacity
cDNA archive kit (Applied Biosystems Inc., Foster, CA) according
to the manufacturers’ instructions for real time PCR and regular
PCR analysis.
Microarray experiment for mouse gene array
Total RNA was quantified on a NanoDrop spectrophotometer,
followed by RNA quality assessment on an Agilent 2100
bioanalyzer (Agilent, Palo Alto, CA, USA). Amplification of
cDNA was performed using the Ovation Pico WTA-system V2
RNA amplification system (NuGen Technologies, Inc.). Briefly,
50 ng of total RNA was reverse transcribed using a chimeric
cDNA/mRNA primer, and a second complementary cDNA
strand was synthesized. Purified cDNA was then amplified with
ribo-SPIA enzyme and SPIA DNA/RNA primers (NuGEN
Technologies, Inc.). Amplified ST-cDNA was purified with
Qiagen MinElute reaction cleanup kit. The concentration of
Purified ST-cDNA was measured using the Nanodrop. ST-cDNAs
were fragmented and chemically labeled with biotin to generate
biotinylated ST-cDNA using FL-Ovation cDNA biotin module V2
(NuGen Technologies, Inc.).
Briefly, Affymetrix gene chips, Mouse gene 1.0 ST array
comprised of over 750,000 unique 25-mer oligonucleotide features
constituting over 28000 gene-level probe sets (Affymetrix, Santa
Clara, CA), were hybridized with fragmented and biotin-labeled
target (2.5 mg) in 110 ml of hybridization cocktail. Target
denaturation was performed at 99uC for 2 min and then 45uC
for 5 min, followed by hybridization at 45uC for 18 h with 60 rpm
in hybridization oven 645. Arrays were then washed and stained
with the GeneChip hybridization, wash and stain kit using Gene
chip Fluidic Station 450 according to Affymetrix standard protocol
(www.affymetrix.com). Chips were scanned on an Affymetrix
Gene Chip Scanner 3000 7G, using Command Console Software.
Background correction and normalization were done using
Iterative Plier 16 with GeneSpring V12.0 software (Agilent). 1.5-
fold and 2-fold (p-value ,0.05) differentially expressed gene lists
were generated. The list of differentially expressed genes was
loaded into Ingenuity Pathway Analysis (IPA) 8.0 software (http://
www.ingenuity.com) to perform biological network and functional
analyses.
PCR and Real Time PCR
Quantitative Real-Time (RT)-PCR was performed on the ABI
PRISM 7000 Sequence Detection System using TaqMan Univer-
sal PCR Master Mix (Applied Biosystems) and TaqMan Gene
Expression Assays primer/probe (Applied Biosystems; Assay IDs
are listed in Table 1) according to the manufacturer’s instructions.
b- actin (ACTB) primer was used as internal control. Samples were
analyzed in triplicate. Amplification data were analyzed with ABI
prism sequence Detection Software 2.1 (Applied Biosystems). For
regular PCR a pair of oligonucleotide primers IZJ (59–GCTCCA-
CAGTTGGTGCC-39) and IZJ6 (59-ACGTAGGACCTTGC-
TAACTTC-39) was designated for PCR amplification (data not
shown). The reaction consisted of 3 min of denaturation at 94uC,
1 min of denaturation at 94uC, 45 s of annealing at 55uC, and
2 min of extension at 65uC. After 30 cycles, the final products
were extended for 5 min at 72uC. The resulting amplified
fragment of 601 BP was analyzed by 1.2% agarose gel
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Table 1. Table showing the list of primers used for Real Time PCR Analysis.
Gene Name Sequence
CD4 Forward Primer – CTGACTCTGACTCTGGACAA
Reverse Primer- TGAGCTGAGCCACTTTC
Probe: AGTGAACCTGGTGGTGATG
CD8 Forward Primer – TACTTCTGCGCGACGGTT
Reverse Primer – GCAGTTGTAGGAAGGACATC
Probe – ACGAAGCTGACTGTGGTTGA
Aif1 Forward- GCCTGTCTTAACCTGCATCA
Reverse- AGGCATCACTTCCACATCAG
Probe - TGAGGAGATTTCAAAAGC
ITGAM (CD11b) Forward- ACAGCATCAGTACCAGTTCA
Reverse- GATCCCATATGGTCACATTG
Probe- ATCCCTGTTCAGATCAAC
CD52 Forward- AAGCAGCCAGGTTCAAAGTG
Reverse- ATCCTGTTTGTATCTGAATC
Probe – CATTCCTTCTGGTTGTGA
CD74 Forward- TGCTGATGCGTCCAATGTC
Reverse- TACTCCAGGGGTCCAGA
Probe – CATCTGCTCACGAGGTC
CD68 Forward- TAGGACCGCTTATAGCCCAAG
Sequence
Reverse- CTGTAGGTGTCATCGTGAAG
Probe – GTTACTCTCCTGCCATCC
CD19 Forward- ATTGTCTCCGAGGAAACCTG
Reverse- AGTTCTCAACAGCCAGAG
Probe – AAGGTCAGCAGTGTGGC
ACTB Forward- CTTCTACAATGAGCTGCGTGTG
Reverse- GGTCTCAAACATGATCTGG
Probe – CCGTGAAAAGATGACCC
Irgm1 Forward Primer – AGACAGCGTCACTCGGAT
Reverse Primer- AGTAGTGGAGCAGCCTCGCA
Probe – ATCACACAGTTCCTGCG
Irgm2 Forward Primer – ACCGTCCTGGAGCCTGGATT
Reverse Primer – TTGTCGAGCAACGGGGCAAC
Probe- GGTTCTGAGCAGGTTG
Iigp1 Forward- GAAGCAGATGGCAAACCTC
Reverse- TCCCTAAAGGTGTTCAC
Probe – GGACATCCGCCTTAACTGTG
CXCL9 Forward- GAACTCAGCTCTGCCATGAAG
Reverse- ACTAGGGTTCCTCGAACT
Probe – CCTGGAGCAGTGTGGAG
Sequence
CXCL10 Forward- CGTGTTGAGATCATTGCCACGA
Reverse- GGAGCCCTTTTAGACCTTT
Probe – TGAAAGCGTTTAGCCAAAA
GBP2 Forward- ACGTAGGACCTTGCTAACTTC
Reverse- CGAGCTGATGAGACATCCAT
Probe – TTATCAAGAAGAACATGG
GBP10 Forward- CTGTGCAGTCTCAAACCAAG
Reverse- CACAAGTCGTTCTTAGG
Probe- GATGTGGAAAAGGGTGATCC
MHV Induced Innate Immunity and Neuroinflammation
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electrophoresis. Genes used for RT-PCR quantification are shown
in Table 1.
Histopathological Analysis
Mice were sacrificed at day 6 post-inoculation, and liver, brain
and spinal cord tissues were harvested. Spinal cords were kept
aside for RNA work while brain and liver tissues were used for
histopathological studies. 5 mm thin sections were taken from liver
and brain, stained with H& E for routine histological studies [11].
Serial sections were further immunostained with anti nucleocapsid
antibody and anti Iba1 antibody (microglia/macrophage marker)
as in prior studies [12].
Protein Mesoscale Studies
Brain and spinal cord tissues were harvested from mice 6 days
post-inoculation with RSA59. Mock infected mice were also
sacrificed in parallel and brain and spinal cord tissues were
harvested. The tissues were weighed and flash frozen in liquid
nitrogen. During extraction, 150 mg of tissue was lysed in 1 ml of
lysis buffer containing protease inhibitor cocktails. The sample was
homogenized and centrifuged at 14000 rpm for 10 min at 4uC to
remove debris. The protein concentration was determined and
then the protein sample was loaded onto the Mesosclae Discovery
Multiarray assay (MSD) plate.
MSD assays provide a rapid method for measuring the levels of
multiple protein targets within a single volume sample. In a
multiplex assay, an array of capture antibodies against different
targets is patterned on distinct spots in the same well. The mouse
Th1/Th2 9-Plex Assay detects IFN-c, IL-1b, IL-2, IL-4, IL-5,
KC/GRO, IL-10, IL-12 total and TNF-a in a sandwich
immunoassay format. MSD provides a plate that has been pre-
coated with capture antibodies on spatially distinct spots with an
electro chemiluminiscent compound MSD SULFO TAG label.
Analytes in the sample bind to the capture antibodies immobilized
on the working electrode surface; recruitment of the detection
antibodies by bound analytes completes the sandwich. MSD read
buffer is added that provides the appropriate chemical environ-
ment for electrochemiluminescence. The plate is loaded into an
MSD sector instrument for analysis. Inside the sector instrument, a
voltage is applied to the plate electrode which causes the labels
bound to the electrode surface to emit light. The instrument
measures intensity of emitted light to afford a quantitative measure
of the antibodies. Another single-plex plate containing antibody
against IL-6 was also used to detect the presence and quantity of
IL-6 in the protein sample.
Data Analysis
Data analyses were performed GeneSpring software version
12.0 (Agilent Technologies, Inc., Santa Clara, CA). The probe set
signals were calculated with the Iterative Plier 16 summarization
algorithm; baseline to median of all samples was used as baseline
option. Data was filtered by percentile and lower cut off was set at
25. The criteria for differentially expressed genes were set at $ 2-
fold and 1.5-fold changes. Statistical analysis was performed to
compare 2 groups using unpaired T Test with p-value less than or
equal to 0.05. Heat maps were generated from differentially
expressed gene list. The list of differentially expressed genes was
loaded into Ingenuity Pathway Analysis (IPA) 8.0 software (http://
www.ingenuity.com) to perform biological network and functional
analyses.
Results
RSA59 induces acute neuropathology in mice
Four week old C57BL/6 mice were inoculated with RSA59 or
mock-infected with PBS as controls. Three mice were sacrificed 6
days later, the time previously noted to result in peak CNS
inflammation [13]. Sections of brain and liver, stained by H&E
and immunostained for viral antigen and the microglial marker
Iba1, confirmed successful inoculation in two of the RSA59
infected group by presence of encephalitis and hepatic inflamma-
tion in RSA59-infected mice, and no inflammatory lesions in
control mice (Figure S1), similar to prior studies [14].
RNA was extracted from spinal cords of the same RSA59-
infected and control mice. Relative expression levels of RNA
transcripts were determined by quantitative (RT)-PCR using
primer/probe designed specifically from MHV nucleocapsid, and
b-actin primer was used as internal control. Samples were
analyzed in triplicate. Amplification data (Figure S1 I), corrobo-
rates pathology data, showing large numbers of PCR transcripts
present in two of the RSA59 infected mice, whereas no
amplification was observed in control mice and very little
amplification was observed in one of the infected mice.
Innate Immunity Related Genes Are Upregulated due to
RSA59 infection
Affymetrix gene chip array analyses of spinal cord RNA were
initially performed in two control mice and three mice in the
RSA59 infected group. However, the data presented in Figure 1A
includes just two control mice and two RSA59 infected mice
because in the RSA59 infected group one mouse did not get an
effective inoculation as demonstrated by histopthological data as
well as real time PCR data analysis. Affymetrix gene chip array
analysis of spinal cord RNA reveals differential expression of 822
genes in RSA59-infected mice using a 1.5-fold cut off for changes
in expression and a P value #0.05 (Figure1A) as compared to
control mice. Volcano plot of genes expressed in two control and
two infected mice reveals that out of these 822 genes, 681 genes
were upregulated and 141 genes were down regulated in infected
mice. Using a 2-fold cut for significant changes in transcript
expression with respect to control, 493 genes were upregulated
and only 41 genes were down regulated (data not shown). For
remaining studies, we only analyzed the 1.5-fold cut off data.
Affymetrix Expression Console Software was used to identify
specific upregulated and down regulated (Figure 1B) genes. The
down regulated genes mostly belong to non-coding regions of the
mouse genome. The 681 genes upregulated in RSA59 infected
spinal cords include numerous genes involved in innate immune
Table 1. Cont.
Gene Name Sequence
Viral Primer Forward- GCTCCACAGTTGGTGCC
Reverse- ACGTAGGACCTTGCTAACTTC
doi:10.1371/journal.pone.0111351.t001
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inflammation, and can be clustered into groups based on their
function (Figure1C). Among these functional groups, we identified
which genes were most upregulated (4-fold increase and above)
and previously not known to be associated with MHV infection
and inflammation. These genes are shown in Table 2.
Detailed differential expression levels (fold changes) of individ-
ual genes are presented in Table S1. Data reveals that expression
of inflammatory mediators like CXCL10, CXCL9, CCL 5 and
CCL12 is upregulated. RSA59 infection of the mouse spinal cord
is further marked by increased expression of genes involved in IFN
signaling including immunity related GTPase (Irgm2|Igtp,
Irgm1|Igtp), Interferon inducible protein (Guanylate binding
protein; GBP2, GBP3, GBP4, GBP6, GBP8, GBP9), macrophage
activation 2 like protein (GBP10), interferon inducible GTPase
(IiGP1), and T cell related GTPase. MHC-Class–II, Irf1, Irf7 and
Stat1 are also significantly upregulated in the spinal cord of
RSA59 infected mice compared to mock-infected controls.
Conventional T cell (CD4, CD8) and B cell (CD19) transcripts
also show upregulation in microarray analysis, and there is
significant upregulation of CD74, CD11b (ITGAM) and CD52,
known cell surface markers for microglia/monocytes (Figure 1C
and Table S1).
From the list of differentially expressed innate immunity genes,
we targeted 16 genes (16–40-fold upregulated) for mechanistic
pathways analysis. A heat map of these 16 genes from microarray
data is shown in Figure 2A.
Validation of some of the innate immunity related genes
expressed in Microarray Analysis
To validate microarray data, quantitative RT-PCR was
performed using primer/probe (Table 1) for key upregulated
innate immunity genes (Figure 2B and 2C). b-actin primer was
used as internal control. Samples were analyzed in triplicate.
Validation was performed for CD molecules, CXCL, IRGM and
GBP genes; IFNc induced genes IRGM1, IRGM2, GBP2,
GBP10, Iigp1; and CXCL molecules CXCL9 and CXCL10
which were highly upregulated (Figure 2B). There was no
upregulation of CD4 (data not shown) or CD19 (0.9905), and
Figure 1. Volcano Plot of differentially expressed transcripts of two RSA59- (DM) infected mouse spinal cords at day 6 post-
infection compared to two control mock-infected mouse (Mock) spinal cords (A). X-axis represents the log2 values of the fold change
observed for each mRNA transcript while the Y-axis represents the log 10 values of the p-values of the significance tests between replicates for each
transcript. Genes that are up- or down-regulated more than 1.5-fold in RSA59-infected mice compared to control mice are displayed in red. Heat Map
of differentially up-regulated and down-regulated genes (B). Heat map of the 822 genes shown in red in A, shows 681 genes are up-regulated while
only 141 genes are down-regulated in RSA59 infection (DM) in mice compared to mock-infected controls. The color code/dendrogram shows the
expression level increasing from blue in control and gradually moving towards red in infected mice in cases of up-regulated genes, and vice versa in
down-regulated genes (blue in infected mice and gradual shift to red in control mice). Functional cluster of genes involved in innate immune
responses that were differentially expressed by more than 1.5-fold in RSA59-infected spinal cords compared to mock-infected spinal cords (C).
Upregulated genes belong to several gene families known to be involved in apoptosis, microglial activation, complement signaling, soluble factors
like cytokines and chemokines, colony stimulating factors, IFN-induced and activated genes, immunity related GTPases, guanylate binding proteins
and major histocompatibility complex activation. Detailed differential expression levels (fold changes) of individual genes in each functional cluster
are available in Table S1.
doi:10.1371/journal.pone.0111351.g001
Table 2. List of upregulated genes previously not known to be associated with MHV infection and inflammation.
Gene Group Gene Symbol Fold Change
Microglia Specific Genes Aif1 4.141
Mpeg1 4.32
Guanylate Binding Proteins GBP1 7.116
GBP2 29.653
GBP3 16.972
GBP4 10.455
GBP5 9.826
GBP6 12.627
GBP8 9.426
GBP10 27.316
GTPases Gvin1 6.266–6.986
Interferon Activated and Induced Genes ifi204 10.786
ifi205 5.784
ifi27 14.414
ifi30 5.789
iigp1 31.259
IRGM1 17.216
IRGM2 28.333
NLR Card Domain nlrc5 7.803–9.208
T cell specific GTPase Tgtp1 28.285–38.589
doi:10.1371/journal.pone.0111351.t002
MHV Induced Innate Immunity and Neuroinflammation
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Figure 2. Heat map of the highest expressing innate immunity genes (A). 16 genes are highly up-regulated (16-to 38-fold) as compared to
mock-infected control. The color coding dendrogram represents the expression of individual genes which increases from blue (lowest expression) to
red (highest expression). Validation of Affymetrix Microarray Data by Real Time PCR Analysis (B and C). Relative mRNA expressions of some of the
most highly up-regulated genes are quantified by real time PCR to validate data obtained in Microarray Analysis. The genes selected are immunity
MHV Induced Innate Immunity and Neuroinflammation
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little expression of CD8a and CD8b which is also associated with
upregulation of granzyme; thus, despite upregulation of these
conventional T and B cell markers by microarray analysis, it is not
clear whether they are truly upregulated. There was significant
upregulation of microglia-associated CDs, including CD74, CD52,
and CD11b (ITGAM). Allograft inflammatory factor 1 gene (Aif1;
4.563), which encodes Iba-1, a calcium-binding protein upregu-
lated during microglia/macrophage activation and phagocytosis,
was also upregulated (Figure 2C). Overall, RT-PCR validated
microarray data for all upregulated genes examined, except for the
conventional T and B cell markers.
Classical Innate signaling pathway activated in RSA59
infection
Biological network and functional pathways analysis of the
targeted 16 genes performed using Ingenuity Pathway Analysis
(IPA) 8.0 software revealed that most differentially expressed genes
are involved in classical innate immune signaling (Figure 3A). The
figure legend (B) shows the different symbols that have been used
in the functional network (A). IPA analysis identified top molecules
involved in known disease pathways including Tgtp1 (38.533 fold
increase), CXCL9 (33.161), Iigp1 (31.259), CXCL10 (26.204),
PSMB9 (24.247), HLA-DQA1 (19.732), CCL2 (19.421), IRF7
(17.724), and IRGM1/IRGM2 (17.216/28.333). These molecules
influence canonical pathways like Antigen Presentation Pathway,
multiple sclerosis, Hypercytokinemia/Hyperchemokinemia, gran-
ulocyte and Agranulocyte adhesion and diapedesis. The top
disease pathways that are influenced by these genes are endocrine
system disorders, gastrointestinal and immunological diseases,
metabolic disorders and infectious diseases. IPA analysis also
identified five molecules (ifnar, ifng, TRIM24, STAT1 and ifnb1)
that may play important roles upstream of these canonical
pathways.
RSA59 activates the classical M1 microglial activating
pathway
Biological network and functional pathways analysis of the
targeted 16 genes also reveals that some of the differentially
expressed genes may be involved in activation of classical M1
activation pathways (Figure 4A). The figure legend (B) shows the
different symbols that have been used in the functional network
(A).The top molecules involved in M1 microglial activation
pathways are chemokines (CXCL9, CXCL10 and CXCL11),
TNFAIP3, IL-1A, IL-1B, and IL-12rb1. These molecules can also
affect various canonical pathways, including multiple sclerosis,
Hypercytokinemia/Hyperchemokinemia, granulocyte and Agran-
ulocyte adhesion, diapedesis and communication pathways linking
innate and adaptive immune systems. Upstream molecules that
are increased include interferons (IFNAR1 and IFNLR1), TBK1
and CXCL10. CXCL10, produced by infected cells and
astrocytes, can bind to CXCR3 expressing microglia in the
demyelinating plaque while CCL2 can induce the recruitment of
microglia in MS lesions. The top disease pathways influenced
include inflammatory responses, infectious and hematological
diseases, respiratory diseases and skeletal and muscular disorders.
Immunohistochemical evidence of activation of resting
microglia to phagocytotic microglia in RSA59 inflamed
brain
More detailed immunohistochemical analysis of RSA59 infected
brain revealed that there are several nodule formations in inflamed
regions like basal forebrain, anterior commissure basal pons,
midbrain and deep cerebellar white matter at day 6 post-
inoculation. Nodules surrounding inflamed regions stain positive
for Iba-1 (microglia marker) and inflammatory responses include
changes in microglia morphology-from ramified (resting) to
amoeboid (active) (Figure 5C and E), which suggests transforma-
tion of resting microglia to phagocytotic microglia. In the mock
infected brains, most Iba-1 stained cells show ramified morphology
characteristic of resting microglia (Figure 5B and D). Very few
cells in the vicinity of the inflamed regions are CD4+, CD8+ or
CD19+ (data not shown) as seen in previous studies [10,15]. Data
is consistent with mRNA expression by RT- PCR showing a 4- to
5-fold upregulation of the Aif1 gene which encodes Iba-1 protein
(Figure 5C).
Upregulation of IFN-c, IL-12, IL-10 and mKC protein
expression in acute inflamed spinal cord tissues of RSA59
infected mice
To determine protein levels of pro-and anti-inflammatory
cytokines, sandwich immunoarray-based high throughput
MSD96 well Multi-Array and Multispot mouse cytokine assay
was performed for IFN-c, IL-1b, IL-2, IL-4, IL-5, IL-6, mKC/
GRO, IL-10, IL-12, and TNF-a. Analysis of acute inflamed brain
and spinal cord tissue from RSA59-infected mice reveals robust
IFN-c, IL-12, IL-10 and mKC protein expression (Figure 6). Data
corroborates microarray data, showing upregulation of innate
immune related proteins mainly involved in antiviral immune
responses and phagolysosome maturation, such as IFN-c and IL-
12, which stimulates IFN-c secretion. mKC is produced by
activated microglia/macrophages and plays an important role in
inflammation. IL-10 is also upregulated, and is a potent suppressor
of monocyte/macrophage function in secretion of TH1 cytokines,
and helps virus evade the immune system. Results are consistent
with prior evidence that a Th1-biased cytokine/chemokine
response accompanies persistent MHV infection when antigen
presentation is ongoing [16].
Discussion
The current mRNA profiling data demonstrates significant
upregulation of genes involved in innate immune responses during
acute MHV infection. Results are not unexpected, as they are
consistent with histopathological data demonstrating the activation
of microglia and innate immune response in CNS tissues following
intracranial inoculation. Results are also consistent with prior
studies that have examined the role of specific proteins, including
some of the cytokines, chemokines and signaling molecules whose
gene expression was found to be upregulated here. In addition, the
current approaches also identified a number of other genes that
were upregulated in MHV induced neuroinflammation but were
not reported before, and thus warrant further study to explore
their role in MHV infection in CNS cells.
related GTPases (IRGM1, IRGM2), guanylate binding proteins (GBP2, GBP10) and Interferon-gamma inducible GTPase 1 (IIGP1), CXCL9 and CXCL10 (B);
and CD molecules including CD8b, CD19, CD11b, CD74, CD68, CD52 and Iba1 protein coding gene Aif1 are also validated (C). Data shows that IRGM1,
IRGM2, GBP2, GBP10 and IIGP1 are highly up-regulated. Microglia specific CD molecules CD74, CD11b and Aif1 (*Represents significant upregulation.
P value of Aif1 ,0.005) are also enhanced. DM signifies an average of two RSA59 infected mice. (*Represents significant upregulation. P values of
IRGM1 ,0.004, IRGM2 ,0.003, IIGP1 ,0.004, GBP2 ,0.0041, GBP10 ,0.0023, CD74 ,0.002 and CD11b ,0.005).
doi:10.1371/journal.pone.0111351.g002
MHV Induced Innate Immunity and Neuroinflammation
PLOS ONE | www.plosone.org 8 October 2014 | Volume 9 | Issue 10 | e111351
Interestingly, our studies did not find significant changes in
genes involved in lymphocytic activation, with upregulation of T
and B cell markers on microarray failing to be validated by RT-
PCR. Previously, it was shown that that RAG1-/- mice on B6
background infected with RSA59 develop fatal disease but not
WT B6 mice, which supports the importance of adaptive immune
response in this disease [17]. But the fatal disease of RSA59 in
RAG1-/- mice may also be due to hypersensitivity. Moreover,
there is evidence that MHV-A59 (Parental wild type strain of
RSA59) can induce demyelination in the absence of T and B cells
in RAG1-/- mice [18]. Taken together with our current findings,
one possible explanation is that RSA59 may induce virus specific
CD4 and CD8 T cells at day 7 p.i., but at earlier days (day 3
through 6); the majority of the inflammatory cells are microglia.
Direct virus induced neuroinflammation due to the activation of
CNS resident microglia may induce virus-specific CD8 and CD4
T cell responses in the CNS which may play a role in the
augmentation of inflammation. Therefore, our studies mainly
found changes in genes which are known to code microglia/
macrophage specific cell surface molecules and other features of
the innate response, often felt to occur even earlier in acute viral
infection.
Many of the genes undergoing significant upregulation in the
current study encode factors that have previously been shown to
play a role in a variety of acute viral infections. It is well known
that Type I interferons (IFN-a/b) provide a first line of defense
against viral infections by limiting dissemination prior to the
emergence of adaptive immune responses. Viral infection is sensed
by endosomal Toll-like receptors (TLRs), which signal to activate
NF-kB, IFN-regulatory factor 3 (IRF3), IRF7, and downstream
transcription of cytokine and IFN-a/b genes [19,20]. Previous
studies demonstrated that IFN-a/b binding to its receptor induces
Figure 3. Ingenuity Pathway Analysis (IPA) of the 16 genes most highly up-regulated in microarray analysis. A, Functional network
showing the direct and indirect relationships that exist between these molecules which lead to development of immunological diseases. The figure
legend (B) shows the different symbols that have been used in the functional network (A).
doi:10.1371/journal.pone.0111351.g003
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JAK/STAT signaling and upregulation of hundreds of IFN-
stimulated genes (ISGs) in infected and uninfected cells. The
antiviral effector functions triggered by IFN-a/b during a virus
infection involve the concerted action of ISGs. In addition to
direct innate antiviral factors, ISGs comprise cytokines, chemo-
kines, and molecules associated with antigen presentation (MHC
class I), thereby shaping adaptive immune responses [21]. The
classically studied ISGs, RNase L, PKR, and Mx1, disrupt viral
replication and subsequently spread by interfering with both viral
and host cell transcription and translation [22]. However, the
susceptibility to innate antiviral effector mechanisms differs
between viruses and may also be distinct between target organs
as well as cell types and their differentiation state [23,24] has been
reported.
CXCL9 and CXCL10 are known to provide antiviral immune
response in MHV infection. Insertion of CXC chemokine ligands
9 into the MHV genome resulted in protection from viral induced
encephalitis and hepatitis [25,26]. The IFN-induced proteins with
Figure 4. Ingenuity Pathway Analysis (IPA) of the genes involved in M1 microglia/macrophage activation pathways. Functional
network (A) showing the direct and indirect relationships that exist between these molecules which lead to myelin loss. The legends of the symbols
used in the network are given in (B).
doi:10.1371/journal.pone.0111351.g004
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tetratricopeptide repeats (IFIT) are expressed in very low basal
levels but are the most strongly induced ISGs during many viral
infections [27,28,29,30]. One recent study demonstrated that
IFIT2 deficiency results in uncontrolled coronavirus replication
and enhanced encephalitis via impaired IFN-a/b induction in
macrophages [31].
Our current studies also found the alteration of different innate
immune response genes involved in IFN activation pathways,
cytokine/chemokine activation pathways, endosomal Toll like
receptor activation pathways, IRF, and Jack/Stat pathways,
similar to changes noted in the studies mentioned above. But
our current studies also found upregulation of additional molecules
previously unknown to have a role (Table 2), including microglia
specific genes, Guanylate Binding Proteins, GTPases, Interferon
activated and induced genes, NLR Card Domain – 5, and T cell
specific GTPase. The role of individual genes in reducing viral
replication and innate immunity has yet to be characterized. It will
be interesting to explore the role of ISGs in microglia activation
and phagocytosis. Moreover, their contribution to protection in
individual cell types and tissues in vivo warrants further studies. In
general, understanding the role of these genes may enhance the
Figure 5. Relative Iba1 (Aif1) mRNA expression and protein expression in RSA59 (DM strain) infected mice compared to mock
infected control. Real Time PCR analysis of the Aif1 gene expression showed that there is approximately four fold up regulation in RSA59 infected
mice brain compared to mock infection (*Represents significant upregulation. P value of Aif1 ,0.005) (A). Immunohistochemistry with anti Iba1
antibody showed a huge upregulation of microglia specific Iba1 protein expression in RSA59 infected brain section (C) compared to mock infected
control (B). Higher magnification (1000x) of individual microglia in RSA59 infection showed the presence of large cell body and amoeboid processes
(phagocytic in nature) (E). In resting control brain microglia has thin ramified processes and cell size in comparatively smaller. (D).
doi:10.1371/journal.pone.0111351.g005
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knowledge of innate immunity against neurotropic viruses and its
role in shaping the adaptive immune responses.
The role of microglial activation observed in early MHV
infection is similar to its importance in other neurotropic virus
infections, such as HIV induced dementia (HAD) [32,33,34],
Cytomegalovirus infection [35,36], Herpes Simplex Virus (HSV)
infection [37,38], as well as in other neurodegenerative diseases
like Alzheimer’s [39,40,41]. HIV-1 enters the CNS early after
infection, whereas productive replication and macrophage inva-
sion occur years later [42]. Infected microglia harbor viral particles
intracellularly, reflecting their potential as a reservoir. It has
become increasingly apparent that HIV-1-infected microglia
actively secrete both endogenous neurotoxins (TNF-a, IL-1a,
CXCL8/IL-8, glutamate, quinolinic acid, platelet-activating
factor, eicosanoids, and nitric oxide) as well as neurotoxic viral
proteins (Tat, gp120, and gp41). In addition to neurotoxicity, these
viral proteins can also affect microglial cell proliferation [42]. In
Cytomegalovirus infection (HCMV), key defence cells include
microglia and T lymphocytes. In mouse models, antiviral cytokine
TNF-a is produced by the microglial cells and sometimes T
lymphocytes, mainly when they are chemoattracted by CXCL10.
In HSV infection, neuroinflammation is characterized by acute
focal necrotizing encephalitis. Microglial cells express both MHC
class I and class II molecules and produce soluble mediators
TNFa, IL-1a, CXCL10, CCL5, IL-6, CXCL8 and CCL3 [42].
These secreted chemokines may induce neuronal death directly
by activating neuronal chemokine receptors or indirectly by the
activation of microglia mediated autophagic mechanisms [43].
Thus, the activation of microglia and related upregulation of genes
expressed by activated microglia observed in acute MHV infection
is consistent with conserved mechanisms of viral mediated
pathology in other infections, and may be less specific for
demyelinating disease itself.
Protein expression data corroborates microarray data, including
an upregulation of specific Th1 immune related proteins. Many of
these proteins are mainly involved in antiviral immune responses
and phagolysosome maturation, and their upregulation also
suggests acute MHV infection can drive innate and conserved
antiviral responses similar to those seen in other viral infections.
Similar phenomena have been observed in HIV infection in
monocytes/microglia [44]. In contrast to Th1 responses, current
results show almost no upregulation of Th2 cytokines/chemokines.
The combination of increased expression of several canonical Th1
cytokines/chemokines and absence of Th2 cytokines/chemokines
in RSA59 infected tissues supports the hypothesis that the host is
continuing to mount a cell-mediated immune response to RSA59,
as previously suggested [45]. Moreover, our data suggest that
activated microglia/macrophage and inflammatory mediators
contribute to a local CNS microenvironment that regulates viral
replication and IFN-c production during the acute phase of
infection. The potential role of IFN-c despite the limited role of T
cells is intriguing, as initially it was believed that CD4+ T helper
cell type 1 (Th1) lymphocytes, CD8+ cytotoxic lymphocytes, and
NK cells exclusively produced IFN- c [46,47]. However, there is
now evidence that other cells, such as B cells, NKT cells, and
professional antigen-presenting cells (APCs) [monocyte/macro-
phage, dendritic cells (DCs)] secrete IFN-c [48,49,50,51]. IFN-c
production by monocyte/macrophage, DCs acting locally may be
important in self-activation and activation of nearby cells [50,51].
While IFN c is produced in T cells, its upregulation has also
occurred in T cell deficient nude mice, leading to the conclusion
that macrophages can also play a role in this in vivo response of
IFN-c secretion [52,53], and during viral infections, macrophages
are among the first cells in any organ to be exposed and are likely
the major producers of IFN-c soon after infection.
IFN-c can further self-activate microglia, promoting phagoly-
some maturation and phagocytosis of the myelin sheath, which
may partially explain how demyelination, which starts as early as
day 5 post-inoculation and reaches its peak around day 30 [54],
occurs. Previous ultrastructural studies [10] support this mecha-
nism as well, revealing activated microglia can surround myelin-
ated axons with the myelin sheath getting disrupted with intact
axons. Therefore, one mechanism of demyelination involves
macrophage-mediated myelin stripping through an autophagy
pathway without involving conventional CD4+ and CD8+T cells.
Supporting Information
Figure S1 Representative histopathology and immunohisto-
chemical analysis of RSA59- and mock-infected mouse brain
and liver. Brain tissue from the infected mice whose spinal cord
tissues were processed for affymetrix microarray analysis was
processed for routine histological and immunohistochemical
analysis. A, C, E and G sections are from mock-infected mouse;
B, D, F and H are from representative image of RSA59 infected
mouse; A–B: liver tissues stained with H & E show severe hepatitis
in RSA59 infected mice (B) and no hepatitis lesions in control mice
(A). Sagittal brain sections stained with H& E (C, D), immuno-
stained with anti-Iba-1 (E, F), and with anti-nucleocapsid antibody
(G–H). RSA59 infected mice show encephalitis (D), diffused
staining of Iba-1 (F) and wide spread distribution of viral antigen
(H). Representative section from one infected mice were shown
here. In control mock infected mice there were no encephalitis was
observed (C), resting ramified microglia was observed in E and
there were no viral antigen staining as expected (G). I: Relative
mRNA expression of viral nucleocapsid gene from two RSA59-
(DM) infected mouse spinal cords at day 6 post-infection
compared to two control mock-infected mouse spinal cords. Y-
axis represents the relative expression of viral nucleocapsid gene of
infected and control mice spinal cord and X-axis represents
individual mouse from control and infected group.
(TIF)
Table S1 Differential expressed genes between control and
RSA59 infected mice were clustered based on their function.
Classification of differential expressed genes in the spinal cord
between control and RSA59 infected mice.
(DOC)
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Figure 6. Mouse multiplex array cytokine assay was performed on protein extracts from acute inflamed (day 6 post-infection) brain
and spinal cord tissues from RSA59-infected and mock-infected mice. Expression levels of pro- and anti-inflammatory cytokines reveals up-
regulation of proteins involved in innate immune responses, including IFN-c, IL-12, IL-10 and mKC, similar to gene expression data. (* Represents
significant upregulation. P values for IFN-c is ,0.002, for IL-10 is ,0.005, for IL-12 is ,0.004 and for mKC is ,0.005).
doi:10.1371/journal.pone.0111351.g006
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